Biosimilar Portfolio

About Sun Pharmaceutical

Founded in 1983, Sun Pharma has grown through strategic acquisitions and organic expansion to become a $4.5 billion revenue pharmaceutical giant. The company operates manufacturing facilities across India, USA, Canada, Brazil, Mexico and other countries, serving both developed and emerging markets. Sun Pharma is particularly known for its dermatology franchise and complex generics portfolio, with a growing presence in specialty therapeutics and biosimilars.

About Zydus Lifesciences

Zydus Lifesciences Limited, formerly Cadila Healthcare, is a leading Indian multinational pharmaceutical company founded in 1952. The company operates across the entire pharmaceutical value chain with a strong presence in generic drugs, biosimilars, and consumer healthcare products. With manufacturing facilities in India and the US, Zydus serves markets globally including the United States, Europe, and emerging markets, maintaining a robust pipeline of over 300 molecules under development.

Therapeutic Areas